Methylene Blue Injection, USP Now Available

Share Facebook icon Twitter icon Linkedin icon
February 13, 2025

Meitheal Pharmaceuticals (Meitheal) is pleased to announce the official launch of Methylene Blue Injection, USP:

  • 71288-811-11: Methylene Blue Injection, USP 50mg per 10mL (5mg per mL) (0.5%) SDV

ABOUT METHYLENE BLUE INJECTION, USP

Methylene Blue Injection, USP is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.

For full prescribing information, please click on the following link.

Learn more about Methylene Blue Injection, USP.

New Launches
Alprostadil Injection, USP Now Available

Alprostadil Injection, USP Now Available
This Website Uses Cookies

This website uses cookies to help give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and help us make improvements to our site. You can read more about our use of cookies in our Privacy Policy.

Manage Consent Preferences

Always Active

Necessary cookies enable core functionality such as security and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

These cookies are set to provide quantitative measures of website visitors. Information collected with these cookies is used in operations to measure website performance. With the usage of these cookies we are able to count visits and traffic sources to improve our site. The data is collected in a way that does not directly identify anyone.
Accept all cookies Confirm my choices